Company’s FlexASO programs targeting STATHMIN-2 and UNC13A showed three-fold potency, two-fold biodistribution improvement, improved safety, and greatly reduced off-target activity over standard ASOs QurAlis’ FlexASO™ Splice Modulator Platform designed to improve ASO performance, correct…